<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-13T01:49:33Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.03395" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.03395</identifier>
    <datestamp>2022-10-13T15:23:35Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2022-10-13</dc:date>
  <dc:title>PEG-conjugated bovine hemoglobin enhances efficiency of chemotherapeutic agent Doxorubicin with alleviating DOX-induced splenocardiac toxicity</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.03395</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Data' focus has been not only on the improvement of tumor hypoxia and enhancement of DOX chemotherapeutic efficacy via PEG-conjugated bovine hemoglobin (PCBH), but also on the alleviation of splenocardiac dysregulation in the mice treated with different treatments.</dc:description>
  <dc:subject>malignant tumor; tumor; hemoglobin; oxygen; cardio; cardiovascular; spleen</dc:subject>
  <dc:creator>li bing ting</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>